{"id":"W1991788040","doi":"10.1053/j.seminoncol.2007.10.006","title":"Clinical Benefits and Considerations of Bisphosphonate Treatment in Metastatic Bone Disease","year":2007,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Zoledronic acid; Prostate cancer; Breast cancer; Oncology; Multiple myeloma; Internal medicine; Bone pain; Bone disease; N-terminal telopeptide; Bone resorption; Bisphosphonate; Osteoporosis; Cancer; Alkaline phosphatase; Osteocalcin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006519619,0.0003082863,0.003006266,0.0004478219,0.00002512111,0.000002408717,0.00003017882,0.0003403634,0.00005680698],"category_scores_gemma":[0.0004603889,0.000234416,0.000224102,0.0002770959,0.0002080043,0.00001974102,0.00003712939,0.0003531675,0.00001404754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000631686,"about_ca_system_score_gemma":0.002420693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004396785,"about_ca_topic_score_gemma":0.002302386,"domain_scores_codex":[0.9971954,0.0003223165,0.001575211,0.000441454,0.0001186928,0.0003468774],"domain_scores_gemma":[0.9965941,0.002295638,0.0003935272,0.0002959116,0.00003890298,0.0003819113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001872917,0.001972112,0.01115876,0.00322362,0.0001341022,0.003535011,0.00007269445,3.62239e-7,9.932327e-9,0.0002210871,0.0001112673,0.9793837],"study_design_scores_gemma":[0.006245511,0.003203443,0.007877148,0.01660882,0.002672288,0.0006538157,0.00003401846,0.000007738869,4.48725e-7,0.0003145032,0.9621609,0.0002213326],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004999863,0.992115,3.871138e-7,0.0002373944,0.0002190371,0.001918408,0.0001113056,0.000009342649,0.0003892512],"genre_scores_gemma":[0.0007435011,0.9960253,0.002221863,0.0002167947,0.00001531711,0.0002732334,0.0001703158,0.00002901258,0.0003046434],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9791623,"threshold_uncertainty_score":0.9559208,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1722484196294169,"score_gpt":0.4989749170315599,"score_spread":0.3267264974021431,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}